ArticleDiscover oncology2025

Anti-tumor immune modulation and favorable survival outcomes in uterine corpus endometrial carcinoma: insights from PIK3CA/ARID1A co-mutation analysis.

Dongmei Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.